Showing posts with label US FDA. Show all posts
Showing posts with label US FDA. Show all posts
Tuesday, February 19, 2019

US FDA Accepts Regulatory Submissions for Review of Tafamidis to Treat Transthyretin Amyloid Cardiomyopathy

›
In continuation of my update on  Tafamidis Pfizer Inc. (NYSE: PFE) announced today that the US Food and Drug Administration (FDA) ...
Thursday, February 23, 2012

Prescription Shampoo (with Ivermectin) Approved to Treat Head Lice

›
In continuation of my update on  ivermectin                                      Sklice  Lotion, a prescription-strength shampoo to...
Tuesday, February 21, 2012

Case Western Reserve University - One of the nation's top universities and the best college in Ohio

›
Neuroscientists at Case Western Reserve University School of Medicine have made a dramatic breakthrough in their efforts to find a cure f...
Monday, February 20, 2012

Mobius Therapeutics Receives Final FDA Approval for New Glaucoma Drug Mitosol

›
The U.S. Food and Drug Administration (FDA) has approved Mitosol ( mitomycin for solution) for use in glaucoma surgery. "The appro...
Sunday, February 19, 2012

FDA Approves Kalydeco to Treat Rare Form of Cystic Fibrosis

›
The U.S. FDA approved  Kalydeco  (ivacaftor) for the treatment of a rare form of cystic fibrosis (CF) in patients ages 6 years and older who...
Sunday, February 12, 2012

Erivedge Approved to Treat Basal Cell Carinoma

›
Erivedge(vismodegib) has been approved by the U.S. Food and Drug Administration to treat the most common form of skin cancer, basal cel...
Tuesday, February 7, 2012

FDA Approves Gleevec for Expanded Use in Patients with Rare Gastrointestinal Cancer

›
In continuation of my update on imatinib... FDA Approves Gleevec for Expanded Use in Patients with Rare Gastrointestinal Cancer : The ...
Saturday, February 4, 2012

FDA Approves Jentaduet ((sitagliptin and metformin hydrochloride (HCl) )...

›
In continuation of my update on  sitagliptin and metformin hydrochloride (HCl) U.S. Food and Drug Administration (FDA) approved JANUME...
Sunday, January 29, 2012

FDA Approves BYDUREON™ -- The First and Only Once-Weekly Treatment for Type 2 Diabetes

›
In continuation of my up date on Exenatide... Amylin Pharmaceuticals, Inc. and Alkermes plc today announced that the U.S. Food and Drug ...
1 comment: